OA09807A - "Optically active 5H-pyrrolo [3,4-b] pyrazine derivative. Its preparation and pharmaceutical compositions which contain it". - Google Patents

"Optically active 5H-pyrrolo [3,4-b] pyrazine derivative. Its preparation and pharmaceutical compositions which contain it".

Info

Publication number: OA09807A
Authority: OA; OAPI
Prior art keywords: pyrrolo; contain; preparation; pharmaceutical compositions; optically active
Prior art date: 1991-01-17

Application number

OA60387A

Other languages

French (fr)

Inventor

Claude Cotrel

Gerard Roussel

Original Assignee

Rhone Poulenc Rorer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-01-17

Filing date

1993-06-17

Publication date

1994-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9408772&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA09807(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-06-17 Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa

1994-04-15 Publication of OA09807A publication Critical patent/OA09807A/en

Links

ZMJIPNACONXBCG-UHFFFAOYSA-N 7h-pyrrolo[3,4-b]pyrazine Chemical class C1=CN=C2CN=CC2=N1 ZMJIPNACONXBCG-UHFFFAOYSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Public Health (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

OA60387A 1991-01-17 1993-06-17 "Optically active 5H-pyrrolo [3,4-b] pyrazine derivative. Its preparation and pharmaceutical compositions which contain it". OA09807A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9100490A FR2671800B1 (en)	1991-01-17	1991-01-17	OPTICALLY ACTIVE 5H-PYRROLO [3,4-B] PYRAZINE DERIVATIVE, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT.

Publications (1)

Publication Number	Publication Date
OA09807A true OA09807A (en)	1994-04-15

Family

ID=9408772

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA60387A OA09807A (en)	1991-01-17	1993-06-17	"Optically active 5H-pyrrolo [3,4-b] pyrazine derivative. Its preparation and pharmaceutical compositions which contain it".

Country Status (29)

Country	Link
US (5)	US6319926B1 (en)
EP (2)	EP0495717A1 (en)
JP (1)	JPH06504548A (en)
AR (1)	AR248024A1 (en)
AT (1)	ATE121089T1 (en)
AU (2)	AU671797B2 (en)
CA (1)	CA2099782C (en)
CZ (1)	CZ281011B6 (en)
DE (1)	DE69202060T2 (en)
DK (1)	DK0609210T3 (en)
ES (1)	ES2071486T3 (en)
FI (1)	FI100331B (en)
FR (1)	FR2671800B1 (en)
HU (1)	HU218928B (en)
IE (1)	IE66110B1 (en)
IL (1)	IL100677A (en)
MA (1)	MA22392A1 (en)
MX (1)	MX9200180A (en)
NO (1)	NO179911C (en)
NZ (1)	NZ241313A (en)
OA (1)	OA09807A (en)
PH (1)	PH30982A (en)
PL (1)	PL166976B1 (en)
RU (1)	RU2110519C1 (en)
SK (1)	SK279060B6 (en)
TN (1)	TNSN92004A1 (en)
WO (1)	WO1992012980A1 (en)
YU (1)	YU48878B (en)
ZA (1)	ZA92302B (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2671800B1 (en)	1991-01-17	1993-03-12	Rhone Poulenc Rorer Sa	OPTICALLY ACTIVE 5H-PYRROLO [3,4-B] PYRAZINE DERIVATIVE, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
US5786357A (en) *	1991-12-02	1998-07-28	Sepracor Inc.	Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone
ES2101653B1 (en) *	1995-07-10	1998-04-01	Asturpharma S A	(+) - 6- (5-CHLOROPIRID-2-IL) -7-OXO-VINYLOXICARBONYLLOXI-5,6-DIHYDROPYROL (3,4B) PIRAZINE AND ITS USE FOR A PREPARATION PROCEDURE FOR (+) - 6- (5 -CHLOROPIRID-2-IL) -5- (4-METHYLPIPERAZIN-1-IL) -CARBONYLLOXI-7-OXO-5,6-DIHYDROPYROL (3,4B) PYRAZINE.
US6339086B1 (en) *	1999-05-14	2002-01-15	Swpracor, Inc.	Methods of making and using N-desmethylzopiclone
TW200734459A (en)	1999-10-04	2007-09-16	Ajinomoto Kk	Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria
PT1691811E (en)	2003-12-11	2014-10-30	Sunovion Pharmaceuticals Inc	Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
US20050215521A1 (en) *	2003-12-22	2005-09-29	Karim Lalji	Modafinil combination therapy for improving sleep quality
EP1696959A2 (en) *	2003-12-24	2006-09-06	Sepracor, Inc.	Melatonin combination therapy for improving sleep quality
ATE454140T1 (en) *	2004-02-18	2010-01-15	Sepracor Inc	DOPAMINE AGONIST COMBINATION THERAPY WITH SEDATIVES TO IMPROVE SLEEP QUALITY
CA2557850A1 (en) *	2004-04-05	2005-10-20	Sepracor Inc.	Methods of treatment using eszopiclone
EP1919912A1 (en) *	2005-06-21	2008-05-14	Merck Generics (UK) Limited	Process for enantiomeric separation of zopiclone
EP1904046A4 (en) *	2005-07-06	2008-10-01	Sepracor Inc	COMBINATIONS OF ESZOPICLONE AND O-DESMETHYLVENLAFAXINE, AND METHODS OF TREATING MENOPAUSE AND MOOD, ANXIETY AND COGNITIVE DISORDERS
WO2007006003A2 (en)	2005-07-06	2007-01-11	Sepracor Inc.	Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
US7476737B2 (en) *	2005-09-05	2009-01-13	Dr. Reddy's Laboratories Limited	Eszopiclone process
US20070098788A1 (en) *	2005-10-28	2007-05-03	Gore Subhash P	Non-benzodiazepine hypnotic compositions
EP2314289A1 (en)	2005-10-31	2011-04-27	Braincells, Inc.	Gaba receptor mediated modulation of neurogenesis
BRPI0621028A2 (en) *	2006-01-17	2011-11-29	Glenmark Pharmaceuticals Ltd	process for the preparation of an optically active 5h-pyrrolo [3,4-b] pyrazine derivative
EP1984371A1 (en) *	2006-02-03	2008-10-29	Synthon B.V.	Zopiclone resolution using l-tartaric acid
US20080027223A1 (en) *	2006-03-23	2008-01-31	Teva Pharmaceutical Industries Ltd.	Polymorphs of eszopiclone malate
JP2008543953A (en) *	2006-04-20	2008-12-04	テバファーマシューティカルインダストリーズリミティド	Process for preparing eszopiclone crystalline form A, substantially pure eszopiclone and optically enriched eszopiclone
EP1904499A1 (en) *	2006-06-26	2008-04-02	Teva Pharmaceutical Industries Ltd	Process for the preparation of zopiclone
US7786304B2 (en) *	2006-11-06	2010-08-31	Centaur Pharmaceutical Pvt. Ltd.	Process for the preparation of eszopiclone
TW200846340A (en) *	2007-01-31	2008-12-01	Teva Pharma	Methods for preparing eszopiclone
ATE515259T1 (en) *	2007-05-29	2011-07-15	Lek Pharmaceuticals	PHARMACEUTICAL COMPOSITION CONTAINING ESZOPICLONE
US20080305171A1 (en) *	2007-06-07	2008-12-11	Kristin Anne Arnold	Pyrrolopyrazine, formulations, methods of manufacture, and methods of use there
TW200918534A (en) *	2007-06-25	2009-05-01	Teva Pharma	Racemization process of R-zopiclone
EP2020403A1 (en)	2007-08-02	2009-02-04	Esteve Quimica, S.A.	Process for the resolution of zopiclone and intermediate compounds
US20090198058A1 (en) *	2007-08-06	2009-08-06	Dhananjay Govind Sathe	Process for Preparation of Dextrorotatory Isomer of 6-(5- chloro-pyrid-2-yl)-5-[(4-methyl -1-piperazinyl) carbonyloxy] -7-oxo-6,7-dihydro-5H-pyrrolo [3,4-b] pyrazine (Eszopiclone)
US8198278B2 (en)	2007-12-19	2012-06-12	Sunovion Pharmaceuticals Inc.	Besylate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8198277B2 (en) *	2007-12-19	2012-06-12	Sunovion Pharmaceuticals Inc.	L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US20110053945A1 (en) *	2007-12-19	2011-03-03	Sepracor Inc.	Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihy-dro-5h-pyrrolo[3,4-b]pyrazine
US8269005B2 (en) *	2007-12-19	2012-09-18	Sunovion Pharmaceuticals Inc.	L-malate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-Oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8212036B2 (en) *	2007-12-19	2012-07-03	Sunovion Pharmaceuticals Inc.	Maleate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8268832B2 (en) *	2007-12-19	2012-09-18	Sunovion Pharmaceuticals Inc.	Maleate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
WO2009085972A1 (en) *	2007-12-19	2009-07-09	Sepracor Inc.	Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine
WO2009101634A2 (en) *	2008-02-13	2009-08-20	Lupin Limited	A novel process for the preparation of eszopiclone
EP2300015A4 (en) *	2008-03-12	2011-06-29	Univ Emory	USE OF GABAA RECEPTOR ANTAGONISTS TO TREAT EXCESSIVE SOMNOLENCE AND DISORDERS ASSOCIATED WITH EXCESSIVE SOMNOLENCE
US20090269409A1 (en) *	2008-04-24	2009-10-29	Mukesh Kumar Garg	Pharmaceutical compositions comprising eszopiclone
CN101607961B (en) *	2008-06-18	2011-08-10	天津天士力集团有限公司	Eszopiclone crystal and composition thereof
JP2012508219A (en)	2008-11-07	2012-04-05	シプラ・リミテッド	Method for splitting zopiclone
US20100196286A1 (en) *	2008-12-01	2010-08-05	Armer Thomas A	Inhalation delivery methods and devices
US8555875B2 (en) *	2008-12-23	2013-10-15	Map Pharmaceuticals, Inc.	Inhalation devices and related methods for administration of sedative hypnotic compounds
AU2010208240A1 (en)	2009-01-30	2011-09-22	Sunovion Pharmaceuticals Inc	Coated tablets of 6-(5-chloro-2-pyridyl) -5-[ (4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6, 7-dihydro-5H-pyrrol o [3,4-b] pyrazine and methods for measuring effectiveness of coating
WO2010116385A2 (en)	2009-04-08	2010-10-14	Rubicon Research Private Limited	Pharmaceutical compositions for alleviating unpleasant taste
EP2345654A1 (en)	2010-01-05	2011-07-20	LEK Pharmaceuticals d.d.	Eszopiclone particles and a process for their preparation
EP2345655A1 (en)	2010-01-05	2011-07-20	LEK Pharmaceuticals d.d.	A process for racemisation of 6-(5-chloropyridin-2-yl)-7-(4-methyl-1-piperazinyl)carbonyloxy-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
CN103193779B (en) *	2012-01-05	2016-04-20	成都弘达药业有限公司	A kind of preparation method of Lunesta
US10195150B2 (en) *	2012-12-20	2019-02-05	Kashiv Pharma, Llc	Orally disintegrating tablet formulation for enhanced bioavailability
US9636340B2 (en)	2013-11-12	2017-05-02	Ayyappan K. Rajasekaran	Kinase inhibitors
JP2020007252A (en) *	2018-07-05	2020-01-16	アクティブファーマ株式会社	Method for producing eszopiclone dibenzoyl-D-tartrate, method for producing eszopiclone, and crystal of eszopiclone dibenzoyl-D-tartrate

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2166314A1 (en) *	1972-01-07	1973-08-17	Rhone Poulenc Sa	6-substd 5-(4-methyl 1-piperazinyl)carbonyloxy 7-oxo - 5,6-dihydro-pyrrolo (3,4-b)pyrazines - tranquillizers and anticonvuls
OA04285A (en) *	1972-01-07	1979-12-31	Rhone Poulenc Sa	New derivatives of pyrrolo (3,4-b) pyrazine and their preparation.
AR208414A1 (en) *	1974-11-07	1976-12-27	Rhone Poulenc Ind	PROCEDURE TO OBTAIN NEW DERIVATIVES OF ((ACIL-4PIPERAZINIL-1) CARBONYLOXI-5 PYRROLINONE-2)
US4868214A (en)	1987-11-17	1989-09-19	Analgesic Associates	Onset-hastened/enhanced analgesia
US4962124A (en)	1987-11-17	1990-10-09	Analgesic Associates	Onset-hastened/enhanced antipyretic response
US5102890A (en)	1989-09-05	1992-04-07	Rhone-Poulenc Sante	Pyrrole derivatives, their preparation and pharmaceutical compositions which contain them
FR2671800B1 (en)	1991-01-17	1993-03-12	Rhone Poulenc Rorer Sa	OPTICALLY ACTIVE 5H-PYRROLO [3,4-B] PYRAZINE DERIVATIVE, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
US5786357A (en)	1991-12-02	1998-07-28	Sepracor Inc.	Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone
AU3275993A (en)	1991-12-02	1993-06-28	Sepracor, Inc.	Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (-) zopiclone
US5331000A (en)	1992-03-09	1994-07-19	Sepracor Inc.	Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
US6436926B1 (en) *	1999-05-10	2002-08-20	Medpointe, Inc.	Compositions and methods for treating superficial fungal infections
US7476737B2 (en) *	2005-09-05	2009-01-13	Dr. Reddy's Laboratories Limited	Eszopiclone process
EP1984371A1 (en) *	2006-02-03	2008-10-29	Synthon B.V.	Zopiclone resolution using l-tartaric acid

1991
- 1991-01-17 FR FR9100490A patent/FR2671800B1/en not_active Expired - Fee Related
1992
- 1992-01-15 MA MA22677A patent/MA22392A1/en unknown
- 1992-01-15 NZ NZ241313A patent/NZ241313A/en not_active IP Right Cessation
- 1992-01-15 ZA ZA92302A patent/ZA92302B/en unknown
- 1992-01-16 CA CA002099782A patent/CA2099782C/en not_active Expired - Fee Related
- 1992-01-16 AU AU12264/92A patent/AU671797B2/en not_active Expired
- 1992-01-16 JP JP4504006A patent/JPH06504548A/en active Pending
- 1992-01-16 EP EP92400111A patent/EP0495717A1/en active Pending
- 1992-01-16 AR AR92321649A patent/AR248024A1/en active
- 1992-01-16 EP EP92903994A patent/EP0609210B1/en not_active Expired - Lifetime
- 1992-01-16 IE IE920126A patent/IE66110B1/en not_active IP Right Cessation
- 1992-01-16 DK DK92903994.9T patent/DK0609210T3/en active
- 1992-01-16 DE DE69202060T patent/DE69202060T2/en not_active Expired - Lifetime
- 1992-01-16 HU HU9302063A patent/HU218928B/en unknown
- 1992-01-16 PH PH43784A patent/PH30982A/en unknown
- 1992-01-16 MX MX9200180A patent/MX9200180A/en unknown
- 1992-01-16 WO PCT/FR1992/000031 patent/WO1992012980A1/en not_active Ceased
- 1992-01-16 RU RU93051787A patent/RU2110519C1/en active
- 1992-01-16 CZ CS931380A patent/CZ281011B6/en not_active IP Right Cessation
- 1992-01-16 SK SK719-93A patent/SK279060B6/en not_active IP Right Cessation
- 1992-01-16 PL PL92299834A patent/PL166976B1/en unknown
- 1992-01-16 ES ES92903994T patent/ES2071486T3/en not_active Expired - Lifetime
- 1992-01-16 AT AT92903994T patent/ATE121089T1/en not_active IP Right Cessation
- 1992-01-16 IL IL10067792A patent/IL100677A/en not_active IP Right Cessation
- 1992-01-17 TN TNTNSN92004A patent/TNSN92004A1/en unknown
- 1992-01-17 YU YU5592A patent/YU48878B/en unknown
1993
- 1993-05-26 NO NO931919A patent/NO179911C/en not_active IP Right Cessation
- 1993-06-17 OA OA60387A patent/OA09807A/en unknown
- 1993-07-16 FI FI933248A patent/FI100331B/en active
1995
- 1995-08-30 AU AU30321/95A patent/AU3032195A/en not_active Abandoned
1998
- 1998-07-29 US US09/124,651 patent/US6319926B1/en not_active Expired - Fee Related
2000
- 2000-11-28 US US09/722,438 patent/US6444673B1/en not_active Expired - Lifetime
2002
- 2002-07-23 US US10/200,510 patent/US6864257B2/en not_active Expired - Fee Related
2004
- 2004-09-28 US US10/951,844 patent/US7125874B2/en not_active Expired - Fee Related
2006
- 2006-05-03 US US11/416,570 patent/US7381724B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
SK71993A3 (en)	1993-12-08
FI100331B (en)	1997-11-14
EP0495717A1 (en)	1992-07-22
DE69202060D1 (en)	1995-05-18
AR248024A1 (en)	1995-05-31
CZ281011B6 (en)	1996-05-15
ES2071486T3 (en)	1995-06-16
WO1992012980A1 (en)	1992-08-06
EP0609210A4 (en)	1993-09-17
US6319926B1 (en)	2001-11-20
DK0609210T3 (en)	1995-07-03
CZ138093A3 (en)	1994-02-16
FR2671800A1 (en)	1992-07-24
FI933248A0 (en)	1993-07-16
US20060194806A1 (en)	2006-08-31
AU1226492A (en)	1992-08-27
FR2671800B1 (en)	1993-03-12
RU2110519C1 (en)	1998-05-10
FI933248L (en)	1993-07-16
ATE121089T1 (en)	1995-04-15
IL100677A0 (en)	1992-09-06
US20020193378A1 (en)	2002-12-19
PL166976B1 (en)	1995-07-31
US6864257B2 (en)	2005-03-08
US20050043311A1 (en)	2005-02-24
HUT68915A (en)	1995-08-28
YU48878B (en)	2002-09-19
DE69202060T2 (en)	1995-10-26
AU671797B2 (en)	1996-09-12
NO931919D0 (en)	1993-05-26
IE66110B1 (en)	1995-12-13
EP0609210A1 (en)	1994-08-10
ZA92302B (en)	1992-10-28
IE920126A1 (en)	1992-07-29
SK279060B6 (en)	1998-06-03
US7125874B2 (en)	2006-10-24
IL100677A (en)	1995-11-27
YU5592A (en)	1994-11-15
JPH06504548A (en)	1994-05-26
NO179911B (en)	1996-09-30
MA22392A1 (en)	1992-10-01
HU9302063D0 (en)	1993-10-28
NO179911C (en)	1997-01-08
AU3032195A (en)	1995-11-09
TNSN92004A1 (en)	1993-06-08
CA2099782A1 (en)	1992-07-18
EP0609210B1 (en)	1995-04-12
MX9200180A (en)	1992-07-01
US7381724B2 (en)	2008-06-03
HU218928B (en)	2000-12-28
US6444673B1 (en)	2002-09-03
CA2099782C (en)	2002-12-03
PH30982A (en)	1997-12-23
NO931919L (en)	1993-05-26
NZ241313A (en)	1993-03-26

Publication	Publication Date	Title
FR2671800B1 (en)	1993-03-12	OPTICALLY ACTIVE 5H-PYRROLO [3,4-B] PYRAZINE DERIVATIVE, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
FR2696176B1 (en)	1994-11-10	Piperidine derivatives, their preparation and their therapeutic application.
EE9400356A (en)	1996-04-15	Polyethylene glycol protein conjugates, compounds, their use, method of preparation of conjugates and dosage forms
FR2708608B1 (en)	1995-10-27	N-sulfonylbenzimidazolone derivatives, their preparation, pharmaceutical compositions containing them.
FR2708606B1 (en)	1995-10-27	N-phenylalkylindol-2-one derivatives, their preparation, pharmaceutical compositions containing them.
EP0645136A3 (en)	1996-04-24	Physiologically active substance-prolonged releasing-type pharmaceutical preparation.
FR2697841B1 (en)	1995-01-13	New taxane derivatives, their preparation and the pharmaceutical compositions containing them.
FR2697019B1 (en)	1994-11-25	New taxane derivatives, their preparation and the pharmaceutical compositions containing them.
FR2705671B1 (en)	1995-07-07	New hydroxybiphenyl derivatives, their preparation and the pharmaceutical compositions containing them.
FR2712289B1 (en)	1996-01-05	New taxicin derivatives, their preparation and the pharmaceutical compositions containing them.
FR2717811B1 (en)	1996-04-26	Imidazo [1,2-a] pyrazine-4-one derivatives, their preparation and drugs containing them.
FR2696177B1 (en)	1995-05-12	Piperidine derivatives, their preparation and their therapeutic application.
OA09439A (en)	1992-10-15	"New benzoxazolinonic derivatives, their preparation processes and pharmaceutical compositions which contain them".
FR2691459B1 (en)	1995-06-09	NOVEL PHENOTHIAZINE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2701709B1 (en)	1995-04-07	Purified form of streptogramins, its preparation and the pharmaceutical compositions containing it.
FR2673629B1 (en)	1993-05-07	NOVEL BENZOPYRANE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
FR2699920B1 (en)	1995-02-10	Imidazo [2,1-b] benzothiazole-3-acetamide derivatives, their preparation and their therapeutic use.
FR2677355B1 (en)	1993-08-20	NEW OXAZOLE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2700546B1 (en)	1995-02-17	Imidazo [2,1-b] benzoxazole-3-acetamide derivatives, their preparation and their therapeutic use.
FR2695389B1 (en)	1994-11-04	New derivative of isoindolinone, its preparation and the pharmaceutical compositions which contain it.
FR2697253B1 (en)	1994-12-02	2-Aminopyrimidine-4-carboxamide derivatives, their preparation and their therapeutic use.
FR2685204B1 (en)	1995-06-16	PHARMACEUTICAL COMPOSITIONS FOR THE TRANSCUTANEOUS ADMINISTRATION OF FENFLURAMINE.
FR2699534B1 (en)	1995-02-03	Alpha-thienyl-piperidine-1-ethanol derivatives, their preparation and their therapeutic use.
FR2693194B1 (en)	1994-09-23	Alkanecarboxamide derivatives, their preparation and their therapeutic application.
FR2717814B1 (en)	1996-04-26	1,2,4-Triazolo (4,3-a) pyrazine-4-one derivatives, their preparation and the medicaments containing them.